Inden indgivelse af et radioaktivt lægemiddel til en mor, der ammer, bør det overvejes, om indgivelsen med rimelighed kunne udskydes, indtil moderen er ophørt med at amme.
Before administering a radioactive medicinal product to a mother who is breast-feeding, consideration should be given to whether the administration could be reasonably delayed until the mother has ceased breastfeeding.